IAEA contribution to the development of 64Cu radiopharmaceuticals for theranostic applications.
Jalilian AR, Osso JA Jr, Vera-Araujo J, Kumar V, Harris MJ, Gutfilen B, Guérin B, Li H, Zhuravlev F, Chakravarty R, Alirezapour B, Ávila-Rodríguez MA, Khan IU, Aljammaz I, Assaad T, Luurtsema G, Smith J, Duatti A.
Jalilian AR, et al. Among authors: kumar v.
Q J Nucl Med Mol Imaging. 2020 Dec;64(4):338-345. doi: 10.23736/S1824-4785.20.03302-6. Epub 2020 Oct 7.
Q J Nucl Med Mol Imaging. 2020.
PMID: 33026211
Review.